These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32613848)

  • 1. Urine headspace analysis with field asymmetric ion mobility spectrometry for detection of chronic kidney disease.
    Jokiniitty E; Hokkinen L; Kumpulainen P; Leskinen Y; Lehtimäki T; Oksala N; Roine A
    Biomark Med; 2020 Jun; 14(8):629-638. PubMed ID: 32613848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Invasive Diagnosis of Diabetes by Volatile Organic Compounds in Urine Using FAIMS and Fox4000 Electronic Nose.
    Esfahani S; Wicaksono A; Mozdiak E; Arasaradnam RP; Covington JA
    Biosensors (Basel); 2018 Dec; 8(4):. PubMed ID: 30513787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VOC-based detection of prostate cancer using an electronic nose and ion mobility spectrometry: A novel urine-based approach.
    Heers H; Chwilka O; Huber J; Vogelmeier C; Koczulla AR; Baumbach JI; Boeselt T
    Prostate; 2024 Jun; 84(8):756-762. PubMed ID: 38497426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sniffing Out Urinary Tract Infection-Diagnosis Based on Volatile Organic Compounds and Smell Profile.
    Dospinescu VM; Tiele A; Covington JA
    Biosensors (Basel); 2020 Jul; 10(8):. PubMed ID: 32717983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Pancreatic Cancer by Urine Volatile Organic Compound Analysis.
    Nissinen SI; Roine A; Hokkinen L; Karjalainen M; Venäläinen M; Helminen H; Niemi R; Lehtimäki T; Rantanen T; Oksala N
    Anticancer Res; 2019 Jan; 39(1):73-79. PubMed ID: 30591442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary volatile organic compound markers and colorectal anastomotic leakage.
    Plat VD; Bootsma BT; Neal M; Nielsen K; Sonneveld DJA; Tersteeg JJC; Crolla RMPH; van Dam DA; Cense HA; Stockmann HBAC; Covington JA; de Meij TGJ; Tuynman JB; de Boer NKH; Daams F
    Colorectal Dis; 2019 Nov; 21(11):1249-1258. PubMed ID: 31207011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel tool for noninvasive diagnosis and tracking of patients with inflammatory bowel disease.
    Arasaradnam RP; Ouaret N; Thomas MG; Quraishi N; Heatherington E; Nwokolo CU; Bardhan KD; Covington JA
    Inflamm Bowel Dis; 2013 Apr; 19(5):999-1003. PubMed ID: 23478806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of training and measurement protocol for eNose analysis of urine headspace aimed at prostate cancer diagnosis.
    Capelli L; Bax C; Grizzi F; Taverna G
    Sci Rep; 2021 Oct; 11(1):20898. PubMed ID: 34686703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of colorectal cancer (CRC) by urinary volatile organic compound analysis.
    Arasaradnam RP; McFarlane MJ; Ryan-Fisher C; Westenbrink E; Hodges P; Thomas MG; Chambers S; O'Connell N; Bailey C; Harmston C; Nwokolo CU; Bardhan KD; Covington JA
    PLoS One; 2014; 9(9):e108750. PubMed ID: 25268885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of urinary volatile organic compounds as a novel metabolomic biomarker to assess chronic kidney disease progression.
    Wu HHL; Possell M; Nguyen LT; Peng W; Pollock CA; Saad S
    BMC Nephrol; 2024 Oct; 25(1):352. PubMed ID: 39407183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot study for bladder cancer detection with volatile organic compounds using ion mobility spectrometry: a novel urine-based approach.
    Heers H; Gut JM; Hofmann R; Flegar L; Derigs M; Huber J; Baumbach JI; Koczulla AR; Boeselt T
    World J Urol; 2024 May; 42(1):353. PubMed ID: 38795133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of gut bacterial populations using an electronic e-nose and field asymmetric ion mobility spectrometry: further insights into 'fermentonomics'.
    Arasaradnam RP; Ouaret N; Thomas MG; Gold P; Quraishi MN; Nwokolo CU; Bardhan KD; Covington JA
    J Med Eng Technol; 2012 Oct; 36(7):333-7. PubMed ID: 22764881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Searching for Potential Markers of Glomerulopathy in Urine by HS-SPME-GC×GC TOFMS.
    Ligor T; Zawadzka J; Strączyński G; González Paredes RM; Wenda-Piesik A; Ratiu IA; Muszytowski M
    Molecules; 2021 Mar; 26(7):. PubMed ID: 33804943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary volatile organic compounds and faecal microbiome profiles in colorectal cancer.
    McFarlane M; Millard A; Hall H; Savage R; Constantinidou C; Arasaradnam R; Nwokolo C
    Colorectal Dis; 2019 Nov; 21(11):1259-1269. PubMed ID: 31282600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breath Analysis Using eNose and Ion Mobility Technology to Diagnose Inflammatory Bowel Disease-A Pilot Study.
    Tiele A; Wicaksono A; Kansara J; Arasaradnam RP; Covington JA
    Biosensors (Basel); 2019 Apr; 9(2):. PubMed ID: 31013848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in Gas and Volatile Compound Emissions from Human Urine as It Ages, Measured by an Electronic Nose.
    Esfahani S; Sagar NM; Kyrou I; Mozdiak E; O'Connell N; Nwokolo C; Bardhan KD; Arasaradnam RP; Covington JA
    Biosensors (Basel); 2016 Jan; 6(1):. PubMed ID: 26821055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Faecal volatile organic compounds analysis using field asymmetric ion mobility spectrometry: non-invasive diagnostics in paediatric inflammatory bowel disease.
    van Gaal N; Lakenman R; Covington J; Savage R; de Groot E; Bomers M; Benninga M; Mulder C; de Boer N; de Meij T
    J Breath Res; 2017 Nov; 12(1):016006. PubMed ID: 28439048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive Detection of Bladder Tumors Through Volatile Organic Compounds: A Pilot Study with an Electronic Nose.
    Heers H; Gut JM; Hegele A; Hofmann R; Boeselt T; Hattesohl A; Koczulla AR
    Anticancer Res; 2018 Feb; 38(2):833-837. PubMed ID: 29374709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FAIMS analysis of urine gaseous headspace is capable of differentiating ovarian cancer.
    Niemi RJ; Roine AN; Eräviita E; Kumpulainen PS; Mäenpää JU; Oksala N
    Gynecol Oncol; 2018 Dec; 151(3):519-524. PubMed ID: 30257785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards optimizing the protocol for untargeted profiling of urine volatiles via gas chromatography-ion mobility spectrometry. A pilot study.
    Novakova S; Czippelova B; Baranovicova E; Sarlinova M; Urbanova A; Hatokova Z; Dzian A; Banovcin P; Strnadel J; Novak P; Horvath G; Halasova E; Skovierova H
    J Physiol Pharmacol; 2024 Apr; 75(2):215-222. PubMed ID: 38736268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.